AI-powered organoid handling
Traditional drug testing is slow, expensive, and unreliable, with 90% of animal-tested drugs failing in humans. Organoids—miniature lab-grown human organs—offer a better alternative, but their use is limited by manual, inconsistent workflows. Visienco solves this with Orgadroid, an AI-powered benchtop device that automates organoid sorting with precision and scalability. Developed at CSEM, this technology ensures high-quality organoids, accelerating drug discovery, diagnostics, and personalized medicine—while reducing the need for animal testing.